NCT06711679View on ClinicalTrials.gov

Exploring the Minimum Effective Concentration and Volume of Ropivacaine for Sacral Plexus Anesthesia

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

May 10, 2024

Primary Completion Date

December 20, 2024

Study Completion Date

March 20, 2026

Conditions
Pediatric ALL
Interventions
DRUG

Low-dose ropivacaine

0.5 ml/Kg ropivacaine

DRUG

Medium-dose of ropivacaine

1ml/Kg ropivacaine

DRUG

High-dose ropivacaine

1.5 ml/Kg ropivacaine

Trial Locations (1)

430030

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
collaborator

Henan Provincial People's Hospital

OTHER

collaborator

Wuhan Children's Hospital

OTHER

lead

Yilin Zhao

OTHER